drugset
drugset / Trial / NCT05154123

Drug-drug Interaction Study of Rosuvastatin and AT-527 (R07496998)

NCT05154123 ↗

Phase 1 Completed 29 enrolled Atea Pharmaceuticals, Inc. Hoffmann-La Roche · collab
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Drug-drug interaction study of rosuvastatin and AT-527 (R07496998)

Timeline

Start
2021-11-16
Primary completion
2021-12-23
Completion
2021-12-23

Drugs

EvaluationDrugModalityDoseRoute
Subject AT-527 Other / unclassified — —
Subject Rosuvastatin Small molecule — —

Indications

No indication recorded.